Stryker price target raised to $295 from $250 at Canaccord

Canaccord analyst Kyle Rose raised the firm’s price target on Stryker to $295 from $250 and keeps a Hold rating on the shares. The analyst said they delivered a strong Q1 despite continued supply chain, inflationary, and FX headwinds, beating on the top and bottom lines and raising FY guidance.